1. Basic and Clinical Characteristics of PDE 3 Inhibitors as Cardiotonic Agents

   • Masao Endoh

   Editorial 17 May 2007 Pages: 135 - 139

   

2. Atorvastatin-induced Downregulation of Survivin and Vascular Smooth Muscle Cell Apoptosis: A Causal Relationship in Restenosis?

   • Wolfgang Erl

   Editorial 08 May 2007 Pages: 141 - 144

3. The Mechanism Underlying Vascular Smooth Muscle Cell Apoptosis Induced by Atorvastatin may be Mainly Associated with Down-regulation of Survivin Expression

   • Yi-Guan Xu
   • Sheng-Hua Zhou
   • Shang Chen

   OriginalPaper 20 March 2007 Pages: 145 - 153

   

4. Oral Administration of Candesartan Improves the Survival of Mice with Viral Myocarditis through Modification of Cardiac Adiponectin Expression

   • Seiichiro Saegusa
   • Yu Fei
   • Tsugiyasu Kanda

   OriginalPaper 05 May 2007 Pages: 155 - 160

   

5. Beyond Lipid Lowering: The Anti-Hypertensive Role of Statins

   • Vineet Chopra
   • Palak U. Choksi
   • Erdal Cavusoglu

   REVIEW 28 April 2007 Pages: 161 - 169

   

6. Myocardial Phosphodiesterases and Regulation of Cardiac Contractility in Health and Cardiac Disease

   • Oleg E. Osadchii

   Review 21 March 2007 Pages: 171 - 194

7. Atherosclerosis and Oxidant Stress: The End of the Road for Antioxidant Vitamin Treatment?

   • Mika J. Thomson
   • Valentina Puntmann
   • Juan-Carlos Kaski

   Review 05 May 2007 Pages: 195 - 210

   

8. Anti-inflammatory Actions of Quinapril

   • Jesus Egido
   • Marta Ruiz-Ortega

   Review 03 April 2007 Pages: 211 - 220

   

9. Design and Rationale of the ARBITER 6 Trial (Arterial Biology for the Investigation of the Treatment Effects of Reducing Cholesterol)-6-HDL and LDL Treatment Strategies in Atherosclerosis (HALTS)

   • Patrick J. Devine
   • Mark A. Turco
   • Allen J. Taylor

   OriginalPaper 03 April 2007 Pages: 221 - 225